| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 677,6 k € | +7.0% | 633,5 k € | ||||||||
| Gross margin | 1,3 M € | +7.7% | 1,2 M € | +9.6% | 1,1 M € | +34.2% | 815,8 k € | +16.4% | 700,9 k € | -11.8% | 794,4 k € | -4.0% | 827,1 k € | — | — | |||
| EBITDA | 141,9 k € | +32.6% | 107,0 k € | +25.6% | 85,2 k € | +6.6% | 79,9 k € | +21.9% | 65,6 k € | -9.7% | 72,6 k € | +1.2% | 71,8 k € | +71.2% | 41,9 k € | +9.7% | 38,2 k € | |
| Operating profit | 137,1 k € | +38.3% | 99,1 k € | +26.0% | 78,7 k € | +6.5% | 73,8 k € | +18.2% | 62,5 k € | -7.8% | 67,8 k € | +5.2% | 64,4 k € | +70.1% | 37,9 k € | +7.9% | 35,1 k € | |
| Profit/loss | 72,5 k € | +69.7% | 42,7 k € | +34.1% | 31,9 k € | -4.7% | 33,4 k € | +21.9% | 27,4 k € | +6.0% | 25,9 k € | -4.9% | 27,2 k € | +51.4% | 18,0 k € | -0.4% | 18,1 k € | |
| Equity | 368,4 k € | +24.5% | 295,9 k € | +16.9% | 253,1 k € | +14.4% | 221,3 k € | +17.8% | 187,8 k € | +74.3% | 107,7 k € | +31.6% | 81,9 k € | +49.8% | 54,6 k € | +49.1% | 36,7 k € | |
| Total assets | 660,0 k € | +28.7% | 512,9 k € | +8.0% | 474,8 k € | +22.2% | 388,5 k € | +9.1% | 356,2 k € | +23.3% | 288,8 k € | +2.1% | 282,9 k € | +29.7% | 218,2 k € | +10.2% | 198,0 k € | |
| Cash | 113,5 k € | +125.5% | 50,3 k € | -5.3% | 53,1 k € | +223.0% | 16,5 k € | +140.2% | 6,9 k € | -74.6% | 27,0 k € | +13.8% | 23,7 k € | -16.6% | 28,4 k € | +65.8% | 17,1 k € | |
| Debts | 291,6 k € | +34.4% | 217,0 k € | -2.1% | 221,7 k € | +32.5% | 167,2 k € | -0.7% | 168,4 k € | -7.0% | 181,1 k € | -8.1% | 197,1 k € | +20.5% | 163,6 k € | +1.5% | 161,2 k € | |
| Staff | 8,7 | 8,2 | 7,8 | 6,2 | 5 | 6 | 5,6 | 4,5 | 3,8 | |||||||||
Private limited company · Geel · incorporated on 31/10/2014 · 8,7 ETP
Private limited company profitable and well capitalised. Cash position rising (+125.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CTI Clinical Trial and Consulting Services Belgium is a Private limited company incorporated in 2014. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Geel. It employs on average 8,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette